4.7 • 1.5K Ratings
🗓️ 21 June 2021
⏱️ 81 minutes
🧾️ Download transcript
In this 205th episode I welcome Drs. Essandoh, Cody and Graul back to the show to discuss ECMO including significant new technology and devices that have come into play since I last covered ECMO.
Click on a timestamp to play from that location
0:00.0 | Hello and welcome back to ACRAC. I'm Jed Wolpa and we have a fantastic episode for you today. |
0:21.3 | We are back with the dynamic trio. There's got to be a better word for that, but we have them. |
0:28.8 | Dr. Mike Asando and Dr. Joseph Cody and Thomas Grawl go by Joe and Tommy from the Ohio State |
0:36.4 | University. Frequent listeners will know that they did a fantastic podcast on the use of non-transvenous |
0:43.7 | pacemakers and now we're back to do a really thorough update on ECMO. So we did on ACRAC we did a |
0:50.8 | prior podcast on ECMO with Dr. Scheinberg which was great, but that believe it or not was already |
0:55.4 | years ago and it's such a dynamic field with a lot of new things happening and so this is going |
1:01.2 | to be a great great update for those interested in learning more about what's going on in ECMO. |
1:06.0 | So thank you guys for coming back on the show. Thanks for having us. We're really delighted to be here. |
1:13.6 | Awesome. All right. So let's jump right in and let's talk about some of the kind of background |
1:20.0 | of ECMO what it's used for and what the different options are and Mike if you want to start us off with |
1:25.3 | that I think that'd be great. Perfect. So ECMO which is ESCRACOPORO Membrane Oxygenation has been |
1:32.7 | around since the 70s and it's basically used in two platforms it's for either supporting a failed |
1:40.9 | you know lung or for supporting circulation in the sudden of you know heart failure and heart |
1:47.6 | failure can be heterogeneous can be due to postcardiotomy heartless function can be due to an acute |
1:54.0 | my cardio infarction or also patients who have cardiopulmonary they who undergo arrest |
2:02.0 | we're using ECMO for cardiopulmonary resuscitation. So the two platforms that we'll talk about |
2:09.8 | VinoVenus ECMO which is basically ECMO support and oxygenation mostly for lung failure |
2:17.9 | and they also had a strategies where VinoVino ECMO where you have a failed lung but the right |
2:23.9 | ventricle may not also be working well and there's another kind of relation strategy where |
2:28.8 | you know the protectual canola which we'll get into later on that provides a little bit of support |
2:35.3 | for the right ventricle and also provides the oxygenation for the failed lung so that's all that's |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from Jed Wolpaw, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Jed Wolpaw and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2025.